Stuart Heminway Email

SVP, Regulatory Affairs, BridgeBio Cardiorenal . Eidos Therapeutics

Current Roles

Employees:
63
Revenue:
$4.9M
About
Eidos Therapeutics is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. Eidos seeks to treat this well-defined family of diseases at their collective source by stabilizing TTR.
Eidos Therapeutics Address
101 Montgomery St
San Francisco, CA
United States
Eidos Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.